Osteopontin: a bridge between bone and blood
Authors: Haylock, David N.1; Nilsson, Susan K.
Source: British Journal of Haematology, Volume 134, Number 5, September 2006 , pp. 467-474(8)
Publisher: Blackwell Publishing
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Summary The production of mature blood cells within the bone marrow (BM) is attributed to a pool of haemopoietic stem cells (HSC). It is now evident that HSC reside preferentially at the endosteal region within the BM where bone-lining osteoblasts are a key cellular component of the HSC niche that directly regulates HSC fate. Osteoblasts synthesise proteins that stimulate and inhibit HSC proliferation. In addition to angiopoietin 1 (Ang-1), osteoblasts synthesise and express the highly acidic glycoprotein, osteopontin (Opn), which, like Ang-1, acts as a potent constraining factor on HSC proliferation. Overexpression of Opn is a feature of haemopoietic malignancies, such as multiple myeloma and chronic myeloid leukaemia, although its exact role in the aetiology and progression of these diseases remains unclear. Through osteoblasts and their cell surface and expressed proteins including Opn, bone is able to regulate the tissue that resides within it. In doing so, Opn can be considered a bridge between bone and blood.Keywords: osteopontin; haemopoietic stem cells; niche; bone marrow
Document Type: Research article
DOI: 10.1111/j.1365-2141.2006.06218.x
Affiliations: 1: Niche Laboratory, Australian Stem Cell Centre, Monash University, Clayton, Vic., Australia
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help